Vibrant healthtech cluster of Ghent – including BioLizard – featured in Labiotech

BioLizard is proud to be part of Ghent’s vibrant healthtech cluster, highlighted in Labiotech. The article showcases the city’s thriving biotech, medtech, and digital health ecosystem, where seamless collaboration drives innovation and supports cutting-edge life sciences research.

Ghent, 14th September 2023.

We are proud to part of the thriving community of life sciences, medtech, and digitech experts within the healthcare cluster of Ghent.

This flourishing ecosystem has been featured in an article in Labiotech, which highlights the seamless cooperation across companies, academic institutions, research centres, and healthcare facilities within Ghent.

Read the whole article here to explore the synergy between biotechnology, medical technology, and digital health in Ghent, a thriving European hub for technological innovation – including the exciting contributions of BioLizard.

If you’d like to learn more about how BioLizard can help you with all your data needs, reach out to us today. Let’s transform your data into actionable insights together!

The Business of AI in Biotech: Why biotech is moving beyond the chatbox

The Business of AI in Biotech: Why biotech is moving beyond the chatbox

AI has quickly become part of everyday biotech research, helping scientists navigate information, write code and make sense of complex data. But chat-based tools have their limits. They can provide answers and guidance, but they cannot always do the actual scientific work. As biotech moves beyond the chatbox, the next step is putting AI to work directly within research workflows.